Condensed Consolidated Statements of Stockholders Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in-Capital	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Accumulated Deficit	Total
Balance at Dec. 31, 2021	$ 5,947	$ 7,070,710	$ (1,532)	$ (72,526)	$ (2,396,903)	$ 4,605,696
Balance (in shares) at Dec. 31, 2021	594,729,610			17,074,710
Increase (Decrease) in Stockholders' Equity
Net loss					(156,489)	(156,489)
Other comprehensive income			(16,930)			(16,930)
Stock-based compensation	$ 2	43,384				43,386
Stock-based compensation (in shares)	226,221
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards	$ 3	288				291
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards (in shares)	253,525
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards				$ (1,465)		(1,465)
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards (in shares)				71,627
Provision for common stock warrants		1,743				1,743
Balance at Mar. 31, 2022	$ 5,952	7,116,125	(18,462)	$ (73,991)	(2,553,392)	4,476,232
Balance (in shares) at Mar. 31, 2022	595,209,356			17,146,337
Balance at Dec. 31, 2021	$ 5,947	7,070,710	(1,532)	$ (72,526)	(2,396,903)	4,605,696
Balance (in shares) at Dec. 31, 2021	594,729,610			17,074,710
Increase (Decrease) in Stockholders' Equity
Net loss						(500,543)
Balance at Sep. 30, 2022	$ 5,988	7,245,396	(35,025)	$ (95,337)	(2,897,446)	4,223,576
Balance (in shares) at Sep. 30, 2022	598,777,468			18,015,881
Balance at Mar. 31, 2022	$ 5,952	7,116,125	(18,462)	$ (73,991)	(2,553,392)	4,476,232
Balance (in shares) at Mar. 31, 2022	595,209,356			17,146,337
Increase (Decrease) in Stockholders' Equity
Net loss					(173,296)	(173,296)
Other comprehensive income			(10,527)			(10,527)
Stock-based compensation	$ 2	44,857				44,859
Stock-based compensation (in shares)	108,216
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards	$ 4	525				529
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards (in shares)	391,967
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards				$ (1,195)		(1,195)
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards (in shares)				63,712
Provision for common stock warrants		1,979				1,979
Balance at Jun. 30, 2022	$ 5,958	7,163,486	(28,989)	$ (75,186)	(2,726,688)	4,338,581
Balance (in shares) at Jun. 30, 2022	595,709,539			17,210,049
Increase (Decrease) in Stockholders' Equity
Net loss					(170,758)	(170,758)
Other comprehensive income			(6,036)			(6,036)
Stock-based compensation	$ 1	46,738				46,739
Stock-based compensation (in shares)	113,352
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards	$ 29	1,286				1,315
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards (in shares)	2,954,577
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards				$ (20,151)		(20,151)
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards (in shares)				805,832
Provision for common stock warrants		33,886				33,886
Balance at Sep. 30, 2022	$ 5,988	7,245,396	(35,025)	$ (95,337)	(2,897,446)	4,223,576
Balance (in shares) at Sep. 30, 2022	598,777,468			18,015,881
Balance at Dec. 31, 2022	$ 6,084	7,297,306	(26,004)	$ (96,261)	(3,120,911)	$ 4,060,214
Balance (in shares) at Dec. 31, 2022	608,421,785			18,076,127		608,421,785
Increase (Decrease) in Stockholders' Equity
Net loss					(206,561)	$ (206,561)
Other comprehensive income			6,970			6,970
Stock-based compensation	$ 2	43,300				43,302
Stock-based compensation (in shares)	228,954
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards	$ 6	668				674
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards (in shares)	620,250
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards				$ (2,590)		(2,590)
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards (in shares)				169,787
Exercise of common stock warrants	$ 28	(28)
Exercise of common stock warrants (in shares)	2,680,637
Provision for common stock warrants		19,641				19,641
Balance at Mar. 31, 2023	$ 6,120	7,360,887	(19,034)	$ (98,851)	(3,327,472)	3,921,650
Balance (in shares) at Mar. 31, 2023	611,951,626			18,245,914
Balance at Dec. 31, 2022	$ 6,084	7,297,306	(26,004)	$ (96,261)	(3,120,911)	$ 4,060,214
Balance (in shares) at Dec. 31, 2022	608,421,785			18,076,127		608,421,785
Increase (Decrease) in Stockholders' Equity
Net loss						$ (726,438)
Earnouts from acquisitions paid in stock						8,000
Balance at Sep. 30, 2023	$ 6,243	7,456,196	(1,621)	$ (104,183)	(3,847,349)	$ 3,509,286
Balance (in shares) at Sep. 30, 2023	624,267,053			18,879,367		624,267,053
Balance at Mar. 31, 2023	$ 6,120	7,360,887	(19,034)	$ (98,851)	(3,327,472)	$ 3,921,650
Balance (in shares) at Mar. 31, 2023	611,951,626			18,245,914
Increase (Decrease) in Stockholders' Equity
Net loss					(236,398)	(236,398)
Other comprehensive income			5,270			5,270
Stock-based compensation	$ 3	39,915				39,918
Stock-based compensation (in shares)	338,328
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards	$ 3	55				58
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards (in shares)	246,717
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards				$ (364)		(364)
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards (in shares)				39,349
Exercise of common stock warrants	$ 66	(66)
Exercise of common stock warrants (in shares)	6,623,794
Provision for common stock warrants		951				951
Earnouts from acquisitions paid in stock	$ 9	7,991				8,000
Earnouts from acquisitions paid in stock (in shares)	927,042
Balance at Jun. 30, 2023	$ 6,201	7,409,733	(13,764)	$ (99,215)	(3,563,870)	3,739,085
Balance (in shares) at Jun. 30, 2023	620,087,507			18,285,263
Increase (Decrease) in Stockholders' Equity
Net loss					(283,479)	(283,479)
Other comprehensive income			12,143			12,143
Stock-based compensation	$ 4	45,850				45,854
Stock-based compensation (in shares)	361,162
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards	$ 38	543				581
Stock option exercises and issuance of common stock upon grant/vesting of restricted stock and restricted stock unit awards (in shares)	3,818,384
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards				$ (4,968)		(4,968)
Treasury stock acquired from employees upon exercise of stock options and vesting of restricted stock and restricted stock unit awards (in shares)				594,104
Provision for common stock warrants		70				70
Balance at Sep. 30, 2023	$ 6,243	$ 7,456,196	$ (1,621)	$ (104,183)	$ (3,847,349)	$ 3,509,286
Balance (in shares) at Sep. 30, 2023	624,267,053			18,879,367		624,267,053